Adaptimmune Therapeutics PLC
Total Trades
52
Buys
1
Sells
51
Largest Trade
$1M+
Insiders
8
Institutional Funds
8
Inst. Value
$15K–$50K
Activist Filings
25
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Wood Gavin | CFO | SELL | <$1K | 96K | $0.01 | Sep 3, 2025 |
| Bertrand William C JR | COO | SELL | $1K–$15K | 207K | $0.01 | Aug 29, 2025 |
| EcoR1 Capital, LLC | 10% Owner | SELL | $1M+ | 64.1M | $0.11 | Jul 30, 2025 |
| Norry Elliot | Chief Medical Offi… | SELL | $1K–$15K | 6K | $0.58 | Jan 18, 2025 |
| Lunger John | Chief Patient Supp… | SELL | $1K–$15K | 6K | $0.58 | Jan 18, 2025 |
| Bertrand William C JR | COO | SELL | $1K–$15K | 6K | $0.58 | Jan 18, 2025 |
| Rawcliffe Adrian | CEO | SELL | $15K–$50K | 31K | $0.58 | Jan 18, 2025 |
| Rawcliffe Adrian | CEO | SELL | $15K–$50K | 60K | $0.58 | Jan 15, 2025 |
| Piccina Cintia | Chief Commercial O… | SELL | $1K–$15K | 13K | $0.57 | Jan 15, 2025 |
| Norry Elliot | Chief Medical Offi… | SELL | $1K–$15K | 22K | $0.58 | Jan 15, 2025 |
| Lunger John | Chief Patient Supp… | SELL | $1K–$15K | 20K | $0.58 | Jan 15, 2025 |
| Bertrand William C JR | COO | SELL | $1K–$15K | 20K | $0.58 | Jan 15, 2025 |
| Piccina Cintia | Chief Commercial O… | SELL | $15K–$50K | 25K | $0.93 | Jun 18, 2024 |
| Rawcliffe Adrian | CEO | SELL | $15K–$50K | 39K | $0.70 | Jan 17, 2024 |
| Norry Elliot | Chief Medical Offi… | SELL | $1K–$15K | 21K | $0.69 | Jan 17, 2024 |
| Lunger John | Chief Patient Supp… | SELL | $15K–$50K | 23K | $0.70 | Jan 17, 2024 |
| Bertrand William C JR | COO | SELL | $15K–$50K | 24K | $0.70 | Jan 17, 2024 |
| Rawcliffe Adrian | CEO | SELL | $1K–$15K | 2K | $0.78 | Sep 1, 2023 |
| Lunger John | Chief Patient Supp… | SELL | $1K–$15K | 3K | $0.91 | Aug 1, 2023 |
| Menzel Garry E | Director | SELL | $15K–$50K | 48K | $0.91 | Jul 10, 2023 |
| Rawcliffe Adrian | CEO | SELL | $1K–$15K | 2K | $0.92 | Jun 28, 2023 |
| Piccina Cintia | Chief Commercial O… | SELL | $15K–$50K | 12K | $1.87 | Feb 1, 2023 |
| Lunger John | Chief Patient Supp… | SELL | $1K–$15K | 4K | $1.86 | Jan 18, 2023 |
| Bertrand William C JR | COO | SELL | $1K–$15K | 4K | $1.86 | Jan 18, 2023 |
| Norry Elliot | Chief Medical Offi… | SELL | $1K–$15K | 2K | $1.86 | Jan 18, 2023 |
| Rawcliffe Adrian | CEO | SELL | $15K–$50K | 10K | $1.86 | Jan 18, 2023 |
| Bertrand William C JR | COO | SELL | $15K–$50K | 9K | $1.72 | Jan 13, 2023 |
| Lunger John | Chief Patient Supp… | SELL | $15K–$50K | 9K | $1.72 | Jan 13, 2023 |
| Norry Elliot | Chief Medical Offi… | SELL | $15K–$50K | 11K | $1.72 | Jan 13, 2023 |
| Rawcliffe Adrian | CEO | SELL | $50K–$100K | 32K | $1.72 | Jan 13, 2023 |
| Bertrand William C JR | COO | SELL | $1K–$15K | 4K | $1.69 | Jan 5, 2023 |
| Lunger John | Chief Patient Supp… | SELL | $1K–$15K | 1K | $1.69 | Jan 5, 2023 |
| Norry Elliot | Chief Medical Offi… | SELL | $1K–$15K | 876 | $1.69 | Jan 5, 2023 |
| Rawcliffe Adrian | CEO | SELL | $1K–$15K | 5K | $1.69 | Jan 5, 2023 |
| Rawcliffe Adrian | CEO | SELL | $1K–$15K | 3K | $1.97 | Sep 2, 2022 |
| Lunger John | Chief Patient Supp… | SELL | $1K–$15K | 3K | $1.77 | Aug 2, 2022 |
| Piccina Cintia | Chief Commercial O… | SELL | $15K–$50K | 21K | $1.77 | Aug 2, 2022 |
| Lunger John | Chief Patient Supp… | SELL | $1K–$15K | 2K | $1.68 | Jul 6, 2022 |
| Rawcliffe Adrian | CEO | SELL | $1K–$15K | 3K | $1.63 | Jun 28, 2022 |
| Wood Gavin | CFO | BUY | $1K–$15K | 39K | $0.29 | May 24, 2022 |
| Bertrand William C JR | COO | SELL | $1K–$15K | 4K | $3.19 | Jan 19, 2022 |
| Lunger John | Chief Patient Supp… | SELL | $1K–$15K | 4K | $3.19 | Jan 19, 2022 |
| Norry Elliot | Chief Medical Offi… | SELL | $1K–$15K | 2K | $3.19 | Jan 19, 2022 |
| Rawcliffe Adrian | CEO | SELL | $15K–$50K | 11K | $3.19 | Jan 19, 2022 |
| Bertrand William C JR | COO | SELL | $15K–$50K | 6K | $3.55 | Jan 14, 2022 |
| Lunger John | Chief Patient Supp… | SELL | $15K–$50K | 5K | $3.55 | Jan 14, 2022 |
| Norry Elliot | Chief Medical Offi… | SELL | $15K–$50K | 5K | $3.55 | Jan 14, 2022 |
| Rawcliffe Adrian | CEO | SELL | $50K–$100K | 17K | $3.55 | Jan 14, 2022 |
| Bertrand William C JR | COO | SELL | $1K–$15K | 3K | $4.06 | Jan 6, 2022 |
| Lunger John | Chief Patient Supp… | SELL | $1K–$15K | 1K | $4.06 | Jan 6, 2022 |
Institutional Ownership
13F filings as of Sep 30, 2025 · 8 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Lakeridge Wealth Management LLC | 110K | $1K–$15K | SH |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 41K | $1K–$15K | SH |
| COLUMBIA ADVISORY PARTNERS LLC | 37K | $1K–$15K | SH |
| SG Americas Securities, LLC | 27K | $1K–$15K | SH |
| SIMON QUICK ADVISORS, LLC | 30K | $1K–$15K | SH |
| Wilmington Savings Fund Society, FSB | 604 | <$1K | SH |
| HighMark Wealth Management LLC | 287 | <$1K | SH |
| Investors Research Corp | 100 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Nov 14, 2025
0.0%
0 shares
New Enterprise Associates 14, L.P.
SC 13D/A · Aug 19, 2025
0.0%
4 shares
SC 13G/A · Aug 19, 2025
4.2%
66.0M shares
SC 13G/A · Aug 13, 2025
8.5%
135.5M shares
SC 13G/A · May 15, 2025
8.0%
123.2M shares
SC 13G · Feb 14, 2025
5.8%
89.0M shares
SC 13G/A · Feb 12, 2025
4.6%
70.9M shares
LONG FOCUS CAPITAL MANAGEMENT, LLC
SC 13G/A · Feb 11, 2025
8.0%
20.5M shares
Matrix Capital Management Company LP
SC 13G/A · Jan 8, 2025
0.0%
0 shares
Matrix Capital Management Company LP
SC 13G/A · Dec 5, 2024
8.8%
135.0M shares
Matrix Capital Management Company LP
SC 13G/A · Nov 13, 2024
14.7%
226.1M shares
New Enterprise Associates 14, L.P.
SC 13D/A · Apr 3, 2024
6.7%
102.5M shares
SC 13G/A · Mar 26, 2024
10.7%
164.4M shares
LONG FOCUS CAPITAL MANAGEMENT, LLC 46-2772035
SC 13G/A · Feb 14, 2024
5.3%
12.1M shares
SC 13G/A · Feb 14, 2024
4.8%
65.8M shares
SC 13G · Jan 30, 2024
7.7%
113.4M shares
Baillie Gifford & Co (Scottish partnership)
SC 13G/A · Jan 29, 2024
7.0%
95.5M shares
LONG FOCUS CAPITAL MANAGEMENT, LLC 46-2772035
SC 13G · Nov 8, 2023
2.9%
6.6M shares
Matrix Capital Management Company LP
SC 13G/A · Jul 10, 2023
17.3%
233.8M shares
New Enterprise Associates 14, L.P.
SC 13D/A · Mar 30, 2023
10.3%
102.5M shares
SC 13G/A · Feb 14, 2023
3.0%
6 shares
Baillie Gifford & Co (Scottish partnership)
SC 13G/A · Jan 18, 2023
10.5%
103.0M shares
Baillie Gifford & Co (Scottish partnership)
SC 13G/A · Dec 2, 2022
10.4%
102.6M shares
SC 13G · May 9, 2022
5.8%
6 shares
Baillie Gifford & Co (Scottish partnership)
SC 13G/A · Jan 18, 2022
8.8%
82.5M shares